跳到内容

创伤和急诊医学科

早期贫血管理

Recombinant human erythropoietin therapy in critically ill Jehovah's Witnesses. (打开新窗口)

Ball AM, Winstead PS.

来源‎: Pharmacotherapy 2008;28(11):1383-90.

检索‎: PubMed 18956998

DOI码‎: 10.1592/phco.28.11.1383

https://www.ncbi.nlm.nih.gov/pubmed/18956998 (打开新窗口)

Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia. (打开新窗口)

Chen H, Wu S, Tang M, Zhao R, Zhang Q, Dai Z, Gao Y, Yang S, Li Z, Du Y, Yang A, Zhong L, Lu L, Xu L, Shen X, Liu S, Zhong J, Li X, Lu H, Xiong H, Shen Y, Chen H, Gong S, Xue H, Ge Z

来源‎: N Engl J Med. 2023 2;389(18):1649-59.

检索‎: PubMed 37913505

DOI码‎: 10.1056/NEJMoa2303706

https://pubmed.ncbi.nlm.nih.gov/37913505/ (打开新窗口)

Bloodless management of the anemic patient in the emergency department. (打开新窗口)

Johnson-Arbor K, Verstraete R

来源‎: Ann Emerg Med 2022;79(1):48-57.

检索‎: PubMed 34353645

DOI码‎: 10.1016/j.annemergmed.2021.06.015

https://pubmed.ncbi.nlm.nih.gov/34353645/ (打开新窗口)

Improved survival of critically ill trauma patients treated with recombinant human erythropoietin. (打开新窗口)

Napolitano LM, Fabian TC, Kelly KM, Bailey JA, Block EF, Langholff W, Enny C, Corwin HL.

来源‎: J Trauma 2008;65(2):285-97.

检索‎: PubMed 18695463

DOI码‎: 10.1097/TA.0b013e31817f2c6e

https://www.ncbi.nlm.nih.gov/pubmed/18695463 (打开新窗口)

Erythropoiesis in multiply injured patients. (打开新窗口)

Robinson Y, Hostmann A, Matenov A, Ertel W, Oberholzer A.

来源‎: J Trauma 2006;61(5):1285-91.

检索‎: PubMed 17099548

DOI码‎: 10.1097/01.ta.0000240969.13891.9b

https://www.ncbi.nlm.nih.gov/pubmed/17099548 (打开新窗口)

Erythropoiesis-stimulating agent administration and survival after severe traumatic brain injury: a prospective study. (打开新窗口)

Talving P, Lustenberger T, Inaba K, Lam L, Mohseni S, Chan L, Demetriades D.

来源‎: Arch Surg 2012;147(3):251-5.

检索‎: PubMed 22430906

DOI码‎: 10.1001/archsurg.2011.1838

https://www.ncbi.nlm.nih.gov/pubmed/22430906 (打开新窗口)